Search Within

Abraham Ari Hakimi

Formats
  1. Journal Article (182)
  2. Meeting Abstract (107)
  3. Review (16)
  4. Editorial (12)
  5. Research Letter (4)
  6. Correspondence (3)
  7. Book Section (2)
  8. Guidelines (1)
Groups
  1. Human Oncology and Pathogenesis Program (327)
  2. Surgery (327)
  3. Urology (327)
  4. Department of Medicine (162)
  5. Solid Tumor Oncology Division (155)
  6. Genitourinary Oncology Service (150)

More Groups

People
  1. Paul Russo (139)
  2. Jonathan Coleman (113)
  3. Robert Motzer (102)
  4. Martin Voss (97)
  5. Yingbei Chen (77)
  6. James Hsieh (72)

More People

Years
  1. 2025 (15)
  2. 2024 (18)
  3. 2023 (21)
  4. 2022 (26)
  5. 2021 (34)
  6. 2020 (32)

More Years

Publications
  1. Journal of Clinical Oncology (62)
  2. Urologic Oncology: Seminars and Original Investigations (21)
  3. European Urology (18)
  4. BJU International (17)
  5. Journal of Urology (16)
  6. Modern Pathology (13)

More Publications

Publishers
  1. American Society of Clinical Oncology (64)
  2. Elsevier Science, Inc. (41)
  3. Nature Publishing Group (34)
  4. Elsevier Inc. (30)
  5. American Association for Cancer Research (25)
  6. Wiley Blackwell (25)

More Publishers

Results (327)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer
    Journal Article

    Vanharanta, S.; Shu, W.; Brenet, F.; Ari Hakimi, A.; Heguy, A.; Viale, A.; Reuter, V. E.; Hsieh, J. J. D.; Scandura, J. M.; Massague, J.
    Nature Medicine (2013)

    Fulltext@MSK | Save
  • Genetic determinants of long-term response to rapalog therapy in advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Scott, S. N.; Takeda, S.; Liu, H.; Chen, Y.; Motzer, R. J.; Berger, M. F.; Hsieh, J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Next-generation sequencing reveals genomic determinants of long-term response to mTOR inhibitors in patients with advanced RCC
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Brannon, A. R.; Scott, S.; Takeda, S.; Liu, H.; Chen, Y.; Motzer, R. J.; Berger, M. F.; Hsieh, J. J.
    BJU International (2012)

    Fulltext@MSK | Save
  • Preexisting hypertension is associated with advanced tumor stage but improved cancer specific survival in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Fiegoli, B.; Zabor, E. C.; Bernstein, M.; Furberg-Barnes, A. H.; Russo, P.
    BJU International (2012)

    Fulltext@MSK | Save
  • Tumor suppressor screens of 3p chromatin modulators link BAP1 mutations to poor clinical outcomes in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Ostrovnaya, I.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; more...
    BJU International (2012)

    Fulltext@MSK | Save
  • Prognostic nomogram for renal insufficiency after radical or partial nephrectomy
    Journal Article

    Sorbellini, M.; Kattan, M. W.; Snyder, M. E.; Hakimi, A. A.; Sarasohn, D. M.; Russo, P.
    Journal of Urology (2006)

    Fulltext@MSK | Save
  • Complications of radical and partial nephrectomy in a large contemporary cohort
    Journal Article

    Stephenson, A. J.; Hakimi, A. A.; Snyder, M. E.; Russo, P.
    Journal of Urology (2004)

    Fulltext@MSK | Save